Disorders Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Disorders stocks.

Disorders Stocks Recent News

Date Stock Title
Apr 26 OVID Ovid Therapeutics (OVID) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Apr 26 PXMD PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast
Apr 25 REGN AbbVie's Dermatitis Drug Shown 'Superior' To Sanofi/Regeneron's Dupixent In Head-To-Head Study
Apr 25 REGN Heard on the Street: Bristol-Myers Goes From Big Pharma to Little Pharma
Apr 25 REGN Regeneron (REGN) Reports Next Week: What You Should Expect
Apr 25 REGN UPDATE 1-AbbVie's skin disease drug found to be more effective than Regeneron's Dupixent in study
Apr 25 REGN The Zacks Analyst Blog Highlights Danaher, Regeneron Pharmaceuticals, Palo Alto Networks, Workday and American Electric Power
Apr 25 REGN Regeneron, Mammoth in pact to develop CRISPR-based gene editing therapies
Apr 25 IONS Ionis Publishes 2023 Corporate Responsibility Report
Apr 25 REGN Regeneron to collaborate on gene editing therapies with Doudna-founded Mammoth
Apr 25 REGN Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases
Apr 25 REGN Regeneron expands in gene editing with Mammoth deal
Apr 24 CORT Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Apr 24 REGN Top Stock Reports for Danaher, Regeneron Pharmaceuticals & Palo Alto Networks
Apr 24 REGN Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Apr 23 CORT Corcept (CORT) Posts Positive Data From Cushing's Syndrome Study
Apr 23 PXMD PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101
Apr 23 IONS Ionis to hold first quarter 2024 financial results webcast
Apr 22 REGN Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Apr 22 CORT Mid-Cap Corcept Therapeutics Reveals Data From Hormonal Disorder Study, FDA Application Submission Expected This Quarter
Disorders

Disorder may refer to randomness, non-order, or no intelligible pattern. Disorder may also refer to:

Browse All Tags